Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:38 AM UTC
| NCT Number | NCT06615479 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 440 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company |
| Last Updated on CT.gov | June 26, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT06615479 is currently recruiting participants. This phase3 study for multiple myeloma is actively seeking new participants at 22 locations across the United States. The study is sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06615479 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06615479 was last updated 3 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.